Brennan to chair PhRMA board, with Kindler waiting in the wings

Share this article:
David Brennan
David Brennan
PhRMA's board of directors elected AstraZeneca chief David Brennan as this year's board chairman and Pfizer chairman and CEO Jeff Kindler chairman-elect. Johnson & Johnson's David Norton, company group chairman, worldwide commercial and operations, Pharmaceuticals Group, was elected board treasurer.

Brennan succeeds Merck president and CEO Richard Clark as PhRMA chairman. The votes came at PhRMA's annual meeting in Washington, DC.

In a statement, Clark said: “The PhRMA member companies accomplished much this pas year. We strengthened our marketing code, tightened our DTC advertising principles and voiced strong support of transparency of company interactions with physicians.”

The agenda for the meeting included discussion of policy issues, including healthcare reform and global intellectual property law, as well as medical innovation.

Share this article:

Email Newsletters

More in News

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.

Gilead, Merck HCV marketing battle may be on horizon

Gilead, Merck HCV marketing battle may be on ...

Disclosed in its earnings report yesterday, Gilead may have a card up its sleeve to counter Merck's experimental hep. C combo regimen.

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.